91福利

The IFMBE is an NGO in official relation with WHO. As such, it is called to participate to the WHO General Assembly (GA) and provide inputs presenting amendments, according to the WHO GA Agenda. The IFMBE delegates to the WHO is Prof Marc Nyssen, IFMBE Treasurers, which prepare amendments, collecting inputs by IFMBE AC members and Division Chairs. HTAD Chair Dr Pecchia participated to this discussion and to the drafting of the IFMBE amendments. This year was particular important as the draft of the WHO thirteenth general programme of work, 2019–2023鈥�.

Two amendments were presented.

The International Union for Physical and Engineering Sciences () is the umbrella organization for the International Organization for Medical Physics () and International Federation of Medical and Biological Engineering (). This union is regarded as the world scientific society for biomedical engineering and medical physics and federates more than 100 national societies from all the 6 continents, and the main transnational societies such as or .

Each 3-years, the IUPESM organizes the World Congress on Medical Physics & Biomedical Engineering, which this year was in Prague ().

This was the first time that the 91福利 was so well and successfullyrepresented in this important event!

Dr Pecchia was appointed as Honorary Member of Bosnia and Herzegovina Medical and Biological Engineering Society, for outstanding contribution to development and growth of Biomedical Engineering in Bosnia and Herzegovina.

Prof Tony Esty (Canda) wrote: "March 28th, 2018

Dear Leandro,

It is with great pleasure that the IFMBE/Clinical Engineering Division (http://cedglobal.org/) Awards Committee would like to inform you that your manuscript Health Technology Assessment of Medical Devices in Low and Middle Income Countries: study design and preliminary results, published in the Proceedings of the EMBEC & NBC 2017, was selected as a Best Manuscript for 2018. This award recognizes an individual or a group that published the best clinical engineering-related manuscript in IFMBE conferences proceedings and/or journals published in 2017. The main criteria for the award is that the publication must demonstrate innovation and research contributions by the author/s to the global clinical engineering and healthcare communities, and must help to improve patient outcomes through a combination of the following categories:

1.0 Originality and significant impact upon the clinical engineering field Original contribution to knowledge with an emphasis on the paper鈥檚 innovativeness in one or more of:

1.1 Global interest of subject matter

1.2 Patient safety

1.3 Best practices

2.0 Quality of arguments

2.1 Critical analysis of concepts, theories and findings

2.2 Consistency and coherency

2.3 Clear positioning of paper in existing international literature

3.0 Writing styleQuality of writing style in terms of:

3.1 Readability

3.2 Clarity

3.3 Organization of the article

The committee felt that your manuscript fully meets the above requirements.

Congratulations on receiving this award."

EMERALD is a Marie Sklodowska-Curie Innovative Training Network (MSCA-ITN) funded by the European Union鈥檚 Horizon 2020 Research and Innovation Programme. EMERALD is the coherent action of leading European engineering groups involved in electromagnetic (EM) technology for medical imaging to form a cohort of highly-skilled researchers capable of accelerating the translation of this technology 鈥渇rom the research bench to patient bedside鈥�. EM imaging technology involves the
illumination of the portion of the body under investigation with low-power non-ionizing EM waves in the microwave spectrum and the use of the resultant backscattered signals to generate images of the internal structure of the body.
The objective pursued by EMERALD is to accelerate the translation of research in EM medical imaging into clinical prototypes. To this end, EMERALD will establish a group of 13 outstanding early stage researchers who will be the European leaders in this field, through a unique scientific and training programme. The EMERALD consortium involves academic institutions, industrial partners, hospitals and university medical centers.
Thirteen positions are available on fixed-term contracts for 36 months with a start date in either October 2018 or January 2019, depending on the host institution.
For more info click here.